IFNB1 and cancer: Regarding the interferon family, while IFN-β and IP-10 were not significantly altered, IFN-γ was significantly increased in both solid and haematological malignancy patients, and IL-18 (also called IFN-γ-inducing factor) only in the later cancer group (Figure 3C).